Sana Biotechnology, Inc.’s SANA share price has dipped by 11.16%, which has investors questioning if this is right time to ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial resistance, which the ...

The Tsiino Hiiwiida: unveiling multiple dimensions of plant and fungal biodiversity of the Upper Rio Negro project will accelerate the discovery of plants and fungi in one of the least explored ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...

In October 2024, updated results from the IMMUNOCERV Phase 2 clinical trial in locally advanced cervical cancer patients treated with Versamune ® HPV and chemoradiotherapy were presented at the 66 th ...

Biotechnology has been in use by humans for ... in warfare is not a new concept and has various examples in recorded history. However, advanced biotechnologies can be used to engineer malicious ...

Denver, Colorado--(Newsfile Corp. - March 27, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that ...

One of the most popularly-recognized biotechnology companies ... Registration and web behavior: Account event history, ...

A new book examines Gov. Gavin Newsom's relationship with China during his years running California and raises a variety of red flags about his work with CCP-linked groups.

Learn more about whether Alvotech or Merus N.V. is a better investment based on AAII's A+ Investor grades, which compare both ...

Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...

Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) ("PBM" or "Psyence Biomed"), has announced that it ...